MedTest Announces the US Commercial Launch of Its Direct Hemoglobin A1c, Homocysteine, and Lipoprotein (a) “Lp(a)” Reagents for the Mindray™ BS-480 Chemistry Analyzer

MedTest announces the commercial launch of their Direct Hemoglobin A1c, Homocysteine, and Lipoprotein(a) reagents for the Mindray™ BS-480 Chemistry Analyzer for use in clinical laboratories in the United States and Canada.

The Mindray™ BS-480 Analyzer meets the testing needs of mid-volume laboratories, while offering state-of-the-art features commonly found on large volume analyzers.

MedTest is the exclusive US distributor of the Mindray™ BS-480 Chemistry Analyzer, which is part of the MedTest 480 Ensemble that includes the manufacturing and distribution of reagents, calibrators, and quality control products for the general chemistry and drugs of abuse testing markets. The full menu includes drugs of abuse reagents for urine drug screening, and a full menu of chemistry tests including specialty tests like Hemoglobin A1c and Lipoprotein (a). The new reagents are manufactured specifically for the Mindray™ BS-480 Analyzer and are provided in barcoded containers for ease of use.

Hanjoon Ryu, CEO of MedTest, stated: “MedTest is committed to test menu expansion on the Mindray™ BS-480 Analyzer. Our customers deserve an integrated service provider who offers innovative instruments with expanding test menus, superior customer support and recognized economic advantages. Partnered with the Mindray™ benchtop BS-200 Chemistry Analyzer, the Mindray™ BS-480 Analyzer enables MedTest to offer a unique testing solution for the Integrated Delivery Networks (IDNs) and Group Purchasing Organizations (GPOs) in the United States. Our solution will provide commutable testing results between the core laboratory and satellite laboratory.”